Conditional Stat2 Knockout Mice as a Platform for Modeling Human Diseases

Tess Cremers1, Nataliya Miz2, Alexandra Afanassiev2

  • 1Department of General Surgery, Cooper University Hospital, Camden, NJ 08103, USA.

Immuno
|March 30, 2026
PubMed

Insights

Signal transducer and activator of transcription 2 (STAT2) is crucial for type I interferon signaling in immunity. This study develops STAT2 knockout models to investigate its role in anti-cancer and anti-viral defenses.

Area of Science:

  • Immunology
  • Molecular Biology
  • Genetics

Background:

  • Signal transducer and activator of transcription 2 (STAT2) is essential for type I interferon (IFN-I/III) signaling.
  • This pathway is critical for host defense against viral infections and cancer, and for regulating immune responses.

Purpose of the Study:

  • To expand the utility of conditional Stat2 knockout (KO) mouse models.
  • To validate tissue-specific STAT2 ablation and explore its functional roles in various contexts.

Main Methods:

  • Generation of tissue-specific Stat2 KO mice by crossing floxed Stat2 mice with Cre-driver lines (CMV-Cre, Cdx2-Cre, CD11c-Cre).
  • Validation of STAT2 deletion using PCR genotyping and Western blotting.
  • Assessment of IFN-I signaling pathway function via IFN-β stimulation and analysis of target gene induction.
  • Evaluation of STAT2's role in anti-tumor efficacy and antiviral responses in vivo and in vitro.

Main Results:

  • STAT2 deletion was confirmed in target tissues of the generated KO models.
  • STAT2-deficient cells showed impaired induction of IFN-I target genes upon IFN-β stimulation.
  • Global Stat2 deletion significantly reduced the effectiveness of IFN-β in anti-tumor treatments.
  • Lung fibroblasts from Stat2 KO mice exhibited defective antiviral responses to IFN-β.

Conclusions:

  • The developed tissue-specific Stat2 KO models are valuable tools for studying STAT2 function.
  • These models enable the dissection of STAT2-dependent signaling in a tissue- and disease-specific manner.
  • STAT2 plays a significant role in mediating anti-tumor and antiviral responses through IFN-I signaling.